Your browser doesn't support javascript.
loading
Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.
Cree, Bruce A C; Goldman, Myla D; Corboy, John R; Singer, Barry A; Fox, Edward J; Arnold, Douglas L; Ford, Corey; Weinstock-Guttman, Bianca; Bar-Or, Amit; Mientus, Susanne; Sienkiewicz, Daniel; Zhang, Ying; Karan, Rajesh; Tenenbaum, Nadia.
Affiliation
  • Cree BAC; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco.
  • Goldman MD; Department of Neurology, Virginia Commonwealth University, Richmond.
  • Corboy JR; Rocky Mountain Multiple Sclerosis Center, University of Colorado, Aurora.
  • Singer BA; The Multiple Sclerosis Center for Innovations in Care, Missouri Baptist Medical Center, St Louis.
  • Fox EJ; Central Texas Neurology Consultants, Round Rock.
  • Arnold DL; Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
  • Ford C; University of New Mexico, Albuquerque.
  • Weinstock-Guttman B; Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo.
  • Bar-Or A; Perelman School of Medicine, Department of Neurology, University of Pennsylvania, Philadelphia.
  • Mientus S; Novartis Pharma AG, Basel, Switzerland.
  • Sienkiewicz D; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Zhang Y; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Karan R; Novartis Pharma AG, Basel, Switzerland.
  • Tenenbaum N; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
JAMA Neurol ; 2020 Aug 24.
Article in En | MEDLINE | ID: mdl-32852530

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Language: En Journal: JAMA Neurol Year: 2020 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Language: En Journal: JAMA Neurol Year: 2020 Type: Article